Macrophage Inflammatory Protein 1 and CCR5 as Attractive Therapeutic Targets for HIV Infection

E-ISSN： 2212-4071|1|3|275-280

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.1, Iss.3, 2006-11, pp. : 275-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macrophage chemoattractant protein-1 and macrophage inflammatory protein-1 serum profiles in hypertensive patients with or without significant hyperlipidemia

By Parissis J.T. Venetsanou K.F. Kalantzi M.V. Mentzikof D.G. Ziras N.G. Karas S.M.

European Journal of Internal Medicine, Vol. 11, Iss. 1, 2000-02 ,pp. : 27-32

Elsevier

Access to resources Recommend Favorite

Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment

Current HIV Research, Vol. 7, Iss. 5, 2009-09 ,pp. : 508-518

Bentham Science Publishers

Access to resources Recommend Favorite

Induction of macrophage inflammatory protein-1α and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea

By Ogawa S-i.

Angiogenesis, Vol. 3, Iss. 4, 1999-01 ,pp. : 327-334

Springer Publishing Company

Access to resources Recommend Favorite

Protective Effect of CCR5 Delta-32 Allele Against HIV-1 in Mexican Women

Current HIV Research, Vol. 11, Iss. 6, 2013-09 ,pp. : 506-510

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence for Predominance of CCR5-Using HIV-1 Strains During Highly Active Antiretroviral Therapy

Current HIV Research, Vol. 5, Iss. 2, 2007-03 ,pp. : 221-234

Bentham Science Publishers

Access to resources Recommend Favorite